James Barrett

New Enterprise Associates General Partner

$200k - $40.0m
$10.0m
CompanyDeal TypeAmountDate
Tarveda TherapeuticsSeries D$30MFeb 2017
Galera TherapeuticsSeries B$5MFeb 2016
Tarveda TherapeuticsSeries C$38MJan 2016
Galera TherapeuticsSeries B$37MOct 2015
Proteostasis TherapeuticsSeries B$37MSep 2015
Galera TherapeuticsSeries A$4.7MMar 2015
PhaseBio PharmaceuticalsSeries C$40MMar 2015
Tarveda TherapeuticsSeries B$21MJan 2015
Galera TherapeuticsSeries A$4.7MAug 2014
NexImmuneVenture Round$3M (Lead)Jul 2014
No media found for James Barrett. Add it now.

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb

New Enterprise Associates

New Enterprise Associates

AB

New Enterprise Associates

AM

New Enterprise Associates

AS

New Enterprise Associates